tiprankstipranks
Trending News
More News >
TYK Medicines, Inc. Class H (HK:2410)
:2410
Hong Kong Market

TYK Medicines, Inc. Class H (2410) Financial Statements

Compare
2 Followers

TYK Medicines, Inc. Class H Financial Overview

TYK Medicines, Inc. Class H's market cap is currently HK$4.05B. The company's EPS TTM is HK$-0.340577028; its P/E ratio is ―; TYK Medicines, Inc. Class H is scheduled to report earnings on August 31, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 107.00K¥ 0.00¥ 44.24M
Gross Profit¥ 14.00K¥ 0.00¥ 20.04M
Operating Income¥ -316.80M¥ 0.00¥ -234.79M
EBITDA¥ -346.03M¥ -346.80M¥ -292.22M
Net Income¥ -386.95M¥ -382.43M¥ -310.99M
Balance Sheet
Cash & Short-Term Investments¥ 435.46M¥ 192.83M¥ 243.49M
Total Assets¥ 915.69M¥ 573.14M¥ 558.36M
Total Debt¥ 176.85M¥ 1.33B¥ 82.33M
Net Debt¥ -258.62M¥ 1.14B¥ -8.44M
Total Liabilities¥ 443.13M¥ 1.45B¥ 1.06B
Stockholders' Equity¥ 469.09M¥ -973.82M¥ -505.94M
Cash Flow
Free Cash Flow¥ -381.87M¥ -278.20M¥ -308.23M
Operating Cash Flow¥ -308.25M¥ -200.94M¥ -220.05M
Investing Cash Flow¥ -135.86M¥ 73.01M¥ -158.16M
Financing Cash Flow¥ 632.08M¥ 224.00M¥ 351.14M
Currency in CNY

TYK Medicines, Inc. Class H Earnings and Revenue History

TYK Medicines, Inc. Class H Debt to Assets

TYK Medicines, Inc. Class H Cash Flow

TYK Medicines, Inc. Class H Forecast EPS vs Actual EPS